These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23083527)

  • 1. Effect of missed combined hormonal contraceptives on contraceptive effectiveness: a systematic review.
    Zapata LB; Steenland MW; Brahmi D; Marchbanks PA; Curtis KM
    Contraception; 2013 May; 87(5):685-700. PubMed ID: 23083527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When can a woman start combined hormonal contraceptives (CHCs)? A systematic review.
    Brahmi D; Curtis KM
    Contraception; 2013 May; 87(5):524-38. PubMed ID: 23153903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missed hormonal contraceptives: new recommendations.
    Guilbert E; Black A; Dunn S; Senikas V; ;
    J Obstet Gynaecol Can; 2008 Nov; 30(11):1050-1062. PubMed ID: 19126288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
    Landgren BM; Diczfalusy E
    Contraception; 1984 May; 29(5):437-46. PubMed ID: 6430642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.
    Elomaa K; Lähteenmäki P
    Contraception; 1999 Nov; 60(5):275-9. PubMed ID: 10717779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient understanding of oral contraceptive pill instructions related to missed pills: a systematic review.
    Zapata LB; Steenland MW; Brahmi D; Marchbanks PA; Curtis KM
    Contraception; 2013 May; 87(5):674-84. PubMed ID: 23040136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
    Dragoman M; Curtis KM; Gaffield ME
    Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
    Spona J; Elstein M; Feichtinger W; Sullivan H; Lüdicke F; Müller U; Düsterberg B
    Contraception; 1996 Aug; 54(2):71-7. PubMed ID: 8842582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review.
    Dragoman MV; Simmons KB; Paulen ME; Curtis KM
    Contraception; 2017 Feb; 95(2):117-129. PubMed ID: 27823942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do inadvertent pregnancies occur in oral contraceptive users? Effectiveness of oral contraceptive regimens and interfering factors.
    Fraser IS; Jansen RP
    Contraception; 1983 Jun; 27(6):531-51. PubMed ID: 6413129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The progestogen-only mini-pill.
    Graham S; Fraser IS
    Contraception; 1982 Oct; 26(4):373-88. PubMed ID: 6759029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive safety among women with cystic fibrosis: a systematic review.
    Whiteman MK; Oduyebo T; Zapata LB; Walker S; Curtis KM
    Contraception; 2016 Dec; 94(6):621-629. PubMed ID: 27287694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
    van Heusden AM; Fauser BC
    Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian activity during regular oral contraceptive use.
    Crosignani PG; Testa G; Vegetti W; Parazzini F
    Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian follicles during oral contraceptive cycles: their potential for ovulation.
    Killick SR
    Fertil Steril; 1989 Oct; 52(4):580-2. PubMed ID: 2680616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review.
    Simmons KB; Haddad LB; Nanda K; Curtis KM
    Am J Obstet Gynecol; 2018 Jan; 218(1):88-97.e14. PubMed ID: 28694152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.